SI9520153B - Variante humane DNaze I - Google Patents
Variante humane DNaze I Download PDFInfo
- Publication number
- SI9520153B SI9520153B SI9520153A SI9520153A SI9520153B SI 9520153 B SI9520153 B SI 9520153B SI 9520153 A SI9520153 A SI 9520153A SI 9520153 A SI9520153 A SI 9520153A SI 9520153 B SI9520153 B SI 9520153B
- Authority
- SI
- Slovenia
- Prior art keywords
- human dnase
- amino acid
- actin
- variant
- acid sequence
- Prior art date
Links
- 101000863721 Homo sapiens Deoxyribonuclease-1 Proteins 0.000 title claims abstract 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 11
- 102000007469 Actins Human genes 0.000 claims abstract 7
- 108010085238 Actins Proteins 0.000 claims abstract 7
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- 150000007523 nucleic acids Chemical group 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 101100230463 Caenorhabditis elegans his-44 gene Proteins 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 102000010825 Actinin Human genes 0.000 claims 1
- 108010063503 Actinin Proteins 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 230000013595 glycosylation Effects 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1995/002366 WO1996026278A1 (en) | 1995-02-24 | 1995-02-24 | HUMAN DNase I VARIANTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SI9520153A SI9520153A (sl) | 1998-06-30 |
| SI9520153B true SI9520153B (sl) | 2004-10-31 |
Family
ID=22248728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9520153A SI9520153B (sl) | 1995-02-24 | 1995-02-24 | Variante humane DNaze I |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0811068B1 (cs) |
| JP (1) | JPH11505408A (cs) |
| AT (1) | ATE230027T1 (cs) |
| AU (1) | AU720635B2 (cs) |
| BG (1) | BG64061B1 (cs) |
| BR (1) | BR9510323A (cs) |
| CA (1) | CA2210871C (cs) |
| CZ (1) | CZ288633B6 (cs) |
| DE (1) | DE69529235T2 (cs) |
| DK (1) | DK0811068T3 (cs) |
| ES (1) | ES2188653T3 (cs) |
| HU (1) | HU223272B1 (cs) |
| MX (1) | MX9706428A (cs) |
| NO (1) | NO326612B1 (cs) |
| PL (1) | PL180773B1 (cs) |
| PT (1) | PT811068E (cs) |
| RU (1) | RU2215787C2 (cs) |
| SI (1) | SI9520153B (cs) |
| SK (1) | SK283850B6 (cs) |
| UA (2) | UA66749C2 (cs) |
| WO (1) | WO1996026278A1 (cs) |
| ZA (1) | ZA961419B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK284191B6 (sk) * | 1995-02-24 | 2004-10-05 | Genentech, Inc. | Aktín-rezistentný variant humánnej DNázy I |
| US6391607B1 (en) | 1996-06-14 | 2002-05-21 | Genentech, Inc. | Human DNase I hyperactive variants |
| US7118901B2 (en) | 2002-12-18 | 2006-10-10 | Roche Diagnostics Operations, Inc. | Recombinant bovine pancreatic desoxyribonuclease I with high specific activity |
| EP1433842B1 (en) | 2002-12-18 | 2011-01-05 | Roche Diagnostics GmbH | Recombinant bovine pancreatic desoxyribonuclease I with high specific activity |
| US20150010527A1 (en) * | 2012-02-01 | 2015-01-08 | Protalix Ltd. | Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU630658B2 (en) * | 1988-12-23 | 1992-11-05 | Genentech Inc. | Human dnase |
| US5464817A (en) * | 1990-04-11 | 1995-11-07 | Brigham And Women's Hospital | Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I |
-
1995
- 1995-02-24 EP EP95912611A patent/EP0811068B1/en not_active Expired - Lifetime
- 1995-02-24 CA CA002210871A patent/CA2210871C/en not_active Expired - Fee Related
- 1995-02-24 SI SI9520153A patent/SI9520153B/sl unknown
- 1995-02-24 MX MX9706428A patent/MX9706428A/es not_active IP Right Cessation
- 1995-02-24 PT PT95912611T patent/PT811068E/pt unknown
- 1995-02-24 AT AT95912611T patent/ATE230027T1/de active
- 1995-02-24 CZ CZ19972677A patent/CZ288633B6/cs not_active IP Right Cessation
- 1995-02-24 DE DE69529235T patent/DE69529235T2/de not_active Expired - Lifetime
- 1995-02-24 AU AU19703/95A patent/AU720635B2/en not_active Ceased
- 1995-02-24 ES ES95912611T patent/ES2188653T3/es not_active Expired - Lifetime
- 1995-02-24 JP JP8525640A patent/JPH11505408A/ja not_active Withdrawn
- 1995-02-24 BR BR9510323A patent/BR9510323A/pt not_active IP Right Cessation
- 1995-02-24 HU HU9800180A patent/HU223272B1/hu not_active IP Right Cessation
- 1995-02-24 DK DK95912611T patent/DK0811068T3/da active
- 1995-02-24 UA UA97084355A patent/UA66749C2/xx unknown
- 1995-02-24 WO PCT/US1995/002366 patent/WO1996026278A1/en active IP Right Grant
- 1995-02-24 SK SK1147-97A patent/SK283850B6/sk not_active IP Right Cessation
-
1996
- 1996-02-21 UA UA97084356A patent/UA65523C2/uk unknown
- 1996-02-21 RU RU97115780/13A patent/RU2215787C2/ru not_active IP Right Cessation
- 1996-02-22 ZA ZA9601419A patent/ZA961419B/xx unknown
-
1997
- 1997-07-18 PL PL95321890A patent/PL180773B1/pl not_active IP Right Cessation
- 1997-08-21 BG BG101846A patent/BG64061B1/bg unknown
- 1997-08-22 NO NO19973876A patent/NO326612B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2215787C2 (ru) | 2003-11-10 |
| BG64061B1 (bg) | 2003-11-28 |
| DE69529235D1 (de) | 2003-01-30 |
| CA2210871C (en) | 2009-04-07 |
| SK114797A3 (en) | 1998-02-04 |
| HU223272B1 (hu) | 2004-04-28 |
| NO973876L (no) | 1997-10-24 |
| UA65523C2 (en) | 2004-04-15 |
| NO326612B1 (no) | 2009-01-19 |
| SK283850B6 (sk) | 2004-03-02 |
| DE69529235T2 (de) | 2003-09-04 |
| PL321890A1 (en) | 1997-12-22 |
| ES2188653T3 (es) | 2003-07-01 |
| ATE230027T1 (de) | 2003-01-15 |
| BG101846A (en) | 1998-07-31 |
| ZA961419B (en) | 1997-08-22 |
| EP0811068A1 (en) | 1997-12-10 |
| CZ288633B6 (cs) | 2001-08-15 |
| MX9706428A (es) | 1997-11-29 |
| HUT77422A (hu) | 1998-04-28 |
| AU720635B2 (en) | 2000-06-08 |
| PL180773B1 (pl) | 2001-04-30 |
| WO1996026278A1 (en) | 1996-08-29 |
| UA66749C2 (en) | 2004-06-15 |
| DK0811068T3 (da) | 2003-03-10 |
| JPH11505408A (ja) | 1999-05-21 |
| NO973876D0 (no) | 1997-08-22 |
| CZ267797A3 (cs) | 1998-01-14 |
| BR9510323A (pt) | 1997-11-11 |
| AU1970395A (en) | 1996-09-11 |
| EP0811068B1 (en) | 2002-12-18 |
| CA2210871A1 (en) | 1996-08-29 |
| SI9520153A (sl) | 1998-06-30 |
| PT811068E (pt) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2124203T1 (es) | Inhibidores de elastasa de neutrofilos humanos y catepsina g humana. | |
| NZ284846A (en) | 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| BR9807076B1 (pt) | "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica" | |
| ATE67505T1 (de) | Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| DK0910647T3 (da) | Human DNase i hyperaktive varianter | |
| BG101209A (bg) | Хиполипидемични 1,4-бензотиазепин-1,1-диоксиди | |
| HUP9901144A2 (hu) | Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények | |
| BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
| HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
| FI916077A0 (fi) | Ej glykosylerade proteiner som aer analoga med humant interleukin 3. | |
| RU92016463A (ru) | Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе | |
| SI9520153B (sl) | Variante humane DNaze I | |
| HRP20030215B1 (en) | Chemokine mutants in the tratment of multiple sclerosis | |
| BR0212249A (pt) | Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto | |
| IL102032A0 (en) | 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
| ATE311897T1 (de) | Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone | |
| EG17992A (en) | Preparation of a medicament for arthritis and theumatism | |
| ATE278011T1 (de) | Human dnase ii | |
| ES2067418A1 (es) | Nueva aplicacion de la interleukina-1 beta recombinante humana en el campo de la oftalmologia. | |
| BG101847A (en) | Human dnase i variants | |
| RU97115767A (ru) | Варианты днказы i человека | |
| CA2242562A1 (en) | Human dnase resistant to actin inhibition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF | Valid on the event date |